Long Again9 times tested the bottom now. This looks like a bottom building. After a 2 month's decline we ave reached the October low again.
If there won't be another low today we may see a rebound.
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
4,323 CLP
321.87 B CLP
52.80 T CLP
2.53 B
About Merck & Company, Inc.
Sector
CEO
Robert M. Davis
Headquarters
Rahway
Website
Founded
1891
FIGI
BBG00YFSTJK2
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Merck & Co., Inc. | Chart & Forecast SummaryKey Indicators on Trade Set Up in General
1. Push Set Up
2. Range Set up
3. Break & Retest Set Up
Active Sessions on Relevant Range & Elemented Probabilities;
London(Upwards) - NYC(Downwards)
Conclusion | Trade Plan Execution & Risk Management on Demand;
Overall Consensus | Sell
Looking for a leap on MRK.🔉Sound on!🔉
Thank you as always for watching my videos. I hope that you learned something very educational! Please feel free to like, share, and comment on this post. Remember only risk what you are willing to lose. Trading is very risky but it can change your life!
MerkThe stock Mark presents an excellent opportunity for traders with a favorable risk-benefit ratio. It is currently at a strong demand zone, and there is a bullish shark harmonic pattern that aligns with this demand area, along with the 200-day moving average. This is a strong entry point near 100$, w
MRK-NYSE longterm view"Merck reported a mixed third quarter update on Thursday, cutting guidance even as earnings topped market expectations." according to barron^s.
However, the balance sheet is still solid and MRK entered an area where it presents a good Buy opportunity especially for Dividend portfolio's that want a
Engulfing BottomThe last 3 days we are not getting a new low. Instead the candles are very small and remain withing the seize of the body of the last big red candle.I see this a a strog sign of a bottom.
Merck & Co., Inc. (NYSE: MRK)1. Financial Performance
Q3 2024 Results: Merck reported strong Q3 earnings with worldwide sales of $16.7 billion, reflecting a 4% year-over-year increase. This performance was driven by growth in its oncology and vaccines divisions, particularly from products like Keytruda and Gardasil. The compan
MRK eyes on $111.22: cool number plus a MAJOR landmarkMRK testing a fib that is now clear to everyone.
Break and Retest is the signal to be looking for.
Rejection would make us look at the fibs below.
$ 111.22 is the exact level of interest.
$ 109.61 would make for a good StopLoss.
$ 116.51 will be first target for some profits.
=====================
MRK potential Buy setupReasons for bullish bias:
- Price bounced from the weekly trendline
- Strong weekly bullish closing
- Price is at horizontal support
- No divergence
Here are the recommended trading levels:
Entry Level(CMP): 117.07
Stop Loss Level: 108.81
Take Profit Level 1: 125.33
Take Profit Level 2: 133.00
Take
nice cash flow growing a little bit, it is a buyGreen candle breaks out a ascendent triangule for this stock
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
MRK3671638
Schering-Plough Corporation 6.55% 15-SEP-2037Yield to maturity
5.21%
Maturity date
Sep 15, 2037
Explore more bonds
Curated watchlists where MRKCL is featured.
Frequently Asked Questions
The current price of MRKCL is 99,470 CLP — it hasn't changed in the past 24 hours. Watch MERCK & CO INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BCS exchange MERCK & CO INC stocks are traded under the ticker MRKCL.
MRKCL stock has risen by 0.21% compared to the previous week, the month change is a −2.13% fall, over the last year MERCK & CO INC has showed a 9.48% increase.
We've gathered analysts' opinions on MERCK & CO INC future price: according to them, MRKCL price has a max estimate of 151,219.51 CLP and a min estimate of 97,560.98 CLP. Watch MRKCL chart and read a more detailed MERCK & CO INC stock forecast: see what analysts think of MERCK & CO INC and suggest that you do with its stocks.
MRKCL reached its all-time high on Mar 28, 2024 with the price of 130,550 CLP, and its all-time low was 53,962 CLP and was reached on May 4, 2021. View more price dynamics on MRKCL chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MRKCL stock is 0.53% volatile and has beta coefficient of 0.49. Track MERCK & CO INC stock price on the chart and check out the list of the most volatile stocks — is MERCK & CO INC there?
Today MERCK & CO INC has the market capitalization of 251.79 T, it has increased by 0.36% over the last week.
Yes, you can track MERCK & CO INC financials in yearly and quarterly reports right on TradingView.
MERCK & CO INC is going to release the next earnings report on Feb 4, 2025. Keep track of upcoming events with our Earnings Calendar.
MRKCL earnings for the last quarter are 1.42 K CLP per share, whereas the estimation was 1.34 K CLP resulting in a 5.80% surprise. The estimated earnings for the next quarter are 1.83 K CLP per share. See more details about MERCK & CO INC earnings.
MERCK & CO INC revenue for the last quarter amounts to 15.02 T CLP, despite the estimated figure of 14.85 T CLP. In the next quarter, revenue is expected to reach 15.35 T CLP.
MRKCL net income for the last quarter is 2.85 T CLP, while the quarter before that showed 5.15 T CLP of net income which accounts for −44.74% change. Track more MERCK & CO INC financial stats to get the full picture.
Yes, MRKCL dividends are paid quarterly. The last dividend per share was 713.62 CLP. As of today, Dividend Yield (TTM)% is 3.06%. Tracking MERCK & CO INC dividends might help you take more informed decisions.
MERCK & CO INC dividend yield was 2.72% in 2023, and payout ratio reached 2.07 K%. The year before the numbers were 2.52% and 49.02% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 13, 2024, the company has 72.00 K employees. See our rating of the largest employees — is MERCK & CO INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MERCK & CO INC EBITDA is 16.83 T CLP, and current EBITDA margin is 11.45%. See more stats in MERCK & CO INC financial statements.
Like other stocks, MRKCL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MERCK & CO INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MERCK & CO INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MERCK & CO INC stock shows the sell signal. See more of MERCK & CO INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.